Exosome-nucleic acid aptamer liposome composite drug carrier system as well as preparation method and application thereof

A nucleic acid aptamer and drug-carrying system technology, applied in the field of cancer targeted drug delivery systems, can solve the problems of lack of function of natural liposomes, cumbersome synthesis process, and increased cost, so as to reduce drug resistance and improve drug resistance. Efficacy, good biocompatibility
CN107913408AInactive Publication Date: 2018-04-17CENT SOUTH UNIV
1 Cites 15 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
CENT SOUTH UNIV
Publication Date
2018-04-17
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses an exosome-nucleic acid aptamer liposome composite drug carrier system which comprises an anti-tumor medicine, wherein the surface of the anti-tumor medicine is wrapped by nano-liposomes, a nucleic acid aptamer is connected with the surfaces of the nano-liposomes through chemical bonds to form a nucleic acid aptamer liposome on which the anti-tumor medicine is carried; thenucleic acid aptamer liposome on which the anti-tumor medicine is carried is compounded with exosome. The invention further discloses a preparation method and an application of the composite drug carrier system. The composite drug carrier system is good in targeting property, good in immune evasion property, free of cytotoxicity and not liable to be degraded by macrophage, can be applied to anti-tumor medicine chemotherapy of cancer patients, is capable of greatly improving the treatment effect of anti-tumor medicines, reducing the situations of chemotherapy effect degradation and disease reoccurrence caused by drug resistance, and alleviating the bottle neck problems of conventional chemotherapy of cancer patients, and has great application values and application prospects in intensifyingcancer treatment effects.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to the technical field of cancer targeted drug delivery system, in particular to an exosome-nucleic acid aptamer liposome composite drug delivery system and its preparation method and application. Background technique

[0002] In recent years, the development and research of nano-drug carriers has received extensive attention. Nano-drug carriers have many advantages, such as: nanoparticles are easy to prepare, modified and processed with good controllability, and can protect drugs, genes or functional molecules from degradation by the body or some enzymes, etc. Some nanoparticles, while acting as "carriers", also have the function of immune adjuvants.

[0003] Liposome is an artificial vesicle structure. When the liposome is in water, the hydrophilic head of the phospholipid molecule is inserted into the water, and the hydrophobic tail of the liposome extends to the air. After stirring, a spherical liposome with bilayer l...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More